Skip to main content
logo
BioCryst Pharmaceuticals, Inc. (BMV:BCRX)
Mexico flag Mexico · Delayed Price · Currency is MXN
197.50
-3.50 (-1.74%)
At close: May 23, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Oral Small-molecule and Injectable Protein Therapeutics
450.71M
Log In
Log In
Log In
Log In
Upgrade
Oral Small-molecule and Injectable Protein Therapeutics Growth
36.00%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
385.96M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
33.85%
Log In
Log In
Log In
Log In
Upgrade
Non-United States
51.70M
Log In
Log In
Log In
Log In
Upgrade
Non-United States Growth
37.39%
Log In
Log In
Log In
Log In
Upgrade
Global
13.05M
Log In
Log In
Log In
Log In
Upgrade
Global Growth
140.72%
Log In
Log In
Log In
Log In
Upgrade